Heska Corp (HSKA)

$119.99 0.00 (0.00%)

16:00 EDT HSKA Stock Quote Delayed 30 Minutes

7 A-Rated Healthcare Stocks to Buy for the Long Haul

By Louis Navellier and the InvestorPlace Research Staff Nov 1, 2021

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.

7 Small-Cap Stocks To Buy for Their Big Ambitions

7 Pet Stocks to Buy to Support Our Furry Friends

7 A-Rated Stocks That Look Their Summer Best

More Articles

Volume:

Previous Close -

Market Cap 1.28B

PE Ratio -62.49

EPS -1.92

Volume (Avg. Vol.)

Day's Range -

52-Week Range $115.42 - $119.99

Dividend & Yield N/A (N/A)

HSKA Stock Predictions, Articles, and Heska Corp News

From InvestorPlace
From the Web

10 “Best of the Best” Stocks to Buy for 2017

By Louis Navellier, Editor, Growth Investor Dec 16, 2016

If you're looking for stocks to buy now, look no further. These "best of the best" stocks will get the season started on the right foot.

7 A-Rated Healthcare Stocks to Buy Before Trump Takes Office

By Louis Navellier, Editor, Growth Investor Nov 18, 2016

Donald Trump's incoming administration could dismantle Obamacare, but these healthcare stocks will thrive in the new environment.

5 Top Biotech Stocks to Buy on Trump Victory

By Nov 11, 2016

The case for buying biotech stocks has strengthened following the election of Donald Trump to the White House.

Heska Non-GAAP EPS of $0.17, revenue of $62.4M (NASDAQ:HSKA)

From Seeking Alpha May 5, 2023

Heska press release (NASDAQ:HSKA): Q1 Non-GAAP EPS of $0.17.Revenue of $62.4M (-3.7% Y/Y).

Why Heska Stock Is On Fire Today

From The Motley Fool Apr 3, 2023

A buyout agreement is elevating the pet diagnostics company's shares today.

Heska Non-GAAP EPS of $0.55 beats by $0.22, revenue of $66.34M beats by $1.72M (NASDAQ:HSKA)

From Seeking Alpha Feb 28, 2023

Heska press release (HSKA): Q4 Non-GAAP EPS of $0.55 beats by $0.22.Revenue of $66.34M (-2.5% Y/Y) beats by $1.72M.FY2023 Outlook: Consolidated Revenue of $278M to $288M vs

Wall Street Analysts Are Neutral on Top Healthcare Picks

From TipRanks Nov 9, 2022

Analysts fell to the sidelines weighing in on Heska (

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioCryst (BCRX), ChemoCentryx (CCXI) and Heska (HSKA)

From TipRanks Aug 11, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioCryst (

Analyst Ratings for Heska

From Benzinga May 10, 2022

Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ:HSKA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ADVERTISEMENT